Clinical Trials Logo

Chronic Hepatitis C Virus (HCV) clinical trials

View clinical trials related to Chronic Hepatitis C Virus (HCV).

Filter by:
  • None
  • Page 1

NCT ID: NCT03002818 Completed - Clinical trials for Chronic Hepatitis C Virus (HCV)

Quality of Life Measurement in Treatment Naïve Patients With Hepatitis C Virus (HCV) Genotype 1 (GT1) Suffering From Fatigue and Receiving Ombitasvir, Paritaprevir, and Ritonavir and Dasabuvir (Viekirax®/Exviera®)

HEMATITE
Start date: March 1, 2017
Phase:
Study type: Observational

This is an observational, prospective, open-label, single-arm, multicenter, real-life study designed to observe the impact of paritaprevir/ritonavir/ombitasvir with dasabuvir regimen (Viekirax®/Exviera®, 3D regimen) on total daytime physical activity and fatigue in participants with HCV GT1.

NCT ID: NCT02517528 Completed - Clinical trials for Chronic Hepatitis C Virus (HCV)

ABT-450/Ritonavir/ ABT-267 (ABT-450/r/ABT-267) and ABT-333 Co-Administered With Ribavirin (RBV) in Treatment Naïve and Treatment Experienced Asian Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Compensated Cirrhosis

Start date: July 20, 2015
Phase: Phase 3
Study type: Interventional

This is a Phase 3, open-label, multicenter study evaluating the efficacy and safety of ABT-450/r/ ABT-267 and ABT-333 coadministered with RBV for 12 weeks in HCV genotype 1b, treatment naïve and Interferon (IFN) (alpha, beta or pegIFN) plus RBV treatment-experienced Asian adults with compensated cirrhosis.